Hong TT - Search Results

1

[Synergistic effect of beta-elemene injection combined paclitaxel injection on human breast cancer MB-468 cells: an in vitro study].

Cai DY, Gao X, Wu XH, Hong TT. Cai DY, et al. Among authors: hong tt. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2013 Jul;33(7):978-82. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2013. PMID: 24063225 Chinese.

2

Three vascular endothelial growth factor polymorphisms (-460C>T, -2578C>A, 1612G>A) with cancer risk: a meta-analysis based on 30 case-control studies.

Hong TT, Cai DY, Wu XH, Hua D. Hong TT, et al. Cancer Invest. 2011 Aug;29(7):472-7. doi: 10.3109/07357907.2011.597811. Cancer Invest. 2011. PMID: 21740084

3

Second-line epidermal growth factor receptor inhibitors followed by third-line pemetrexed or the reverse sequence: a retrospective analysis of 83 Chinese patients with advanced lung adenocarcinoma.

Hong T, Zhang R, Cai D, Wu X, Hua D. Hong T, et al. J Cancer Res Clin Oncol. 2012 Feb;138(2):285-91. doi: 10.1007/s00432-011-1084-z. Epub 2011 Nov 25. J Cancer Res Clin Oncol. 2012. PMID: 22116317

4

Polymorphism of vascular endothelial growth factor -1154G>A (rs1570360) with cancer risk: a meta-analysis of 16 case-control studies.

Hong TT, Zhang RX, Wu XH, Hua D. Hong TT, et al. Mol Biol Rep. 2012 May;39(5):5283-9. doi: 10.1007/s11033-011-1326-9. Epub 2011 Dec 14. Mol Biol Rep. 2012. PMID: 22167330

5

[Comparison of the efficacy of second line EGFR TKIs followed by third line pemetrexed or the reverse sequence in the treatment of advanced lung adenocarcinoma].

Zhang RX, Cai DY, Hong TT, Wu XH, Hua D. Zhang RX, et al. Among authors: hong tt. Zhonghua Zhong Liu Za Zhi. 2012 Feb;34(2):147-51. doi: 10.3760/cma.j.issn.0253-3766.2012.02.015. Zhonghua Zhong Liu Za Zhi. 2012. PMID: 22780936 Chinese.

6

Preoperative serum C-reactive protein levels and early breast cancer by BMI and menopausal status.

Hong T, Liu A, Cai D, Zhang Y, Hua D, Hang X, Wu X. Hong T, et al. Cancer Invest. 2013 May;31(4):279-85. doi: 10.3109/07357907.2013.789898. Cancer Invest. 2013. PMID: 23627410

7

A2780 human ovarian cancer cells with acquired paclitaxel resistance display cancer stem cell properties.

Han X, DU F, Jiang L, Zhu Y, Chen Z, Liu Y, Hong T, Wang T, Mao Y, Wu X, Bruce IC, Jin J, Ma X, Hua D. Han X, et al. Oncol Lett. 2013 Nov;6(5):1295-1298. doi: 10.3892/ol.2013.1568. Epub 2013 Sep 6. Oncol Lett. 2013. PMID: 24179511 Free PMC article.

8

Preoperative plasma fibrinogen, but not D-dimer might represent a prognostic factor in non-metastatic colorectal cancer: A prospective cohort study.

Hong T, Shen D, Chen X, Wu X, Hua D. Hong T, et al. Cancer Biomark. 2017;19(1):103-111. doi: 10.3233/CBM-160510. Cancer Biomark. 2017. PMID: 28269756

9

A novel systematic inflammation related index is prognostic in curatively resected non-metastatic colorectal cancer.

Hong T, Shen D, Chen X, Cai D, Wu X, Hua D. Hong T, et al. Am J Surg. 2018 Sep;216(3):450-457. doi: 10.1016/j.amjsurg.2017.07.021. Epub 2017 Jul 19. Am J Surg. 2018. PMID: 28743381

10

CD61+ and CAF+ were found to be good prognosis factors for invasive breast cancer patients.

Cai D, Wu X, Hong T, Mao Y, Ge X, Hua D. Cai D, et al. Pathol Res Pract. 2017 Oct;213(10):1296-1301. doi: 10.1016/j.prp.2017.06.016. Epub 2017 Jun 30. Pathol Res Pract. 2017. PMID: 28935175

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters